Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02512276 · ClinicalTrials.gov registry record · NA
Tele-Pharmacy Intervention to Improve Treatment Adherence
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4,078
- Enrollment target
NCT02512276 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4,078 participants.
The verdict
NCT02512276, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,078 participants
- Enrollment target
Study Summary
The purpose of this cluster randomized controlled trial is to evaluate whether a novel tele-pharmacist-based intervention for patients with hyperlipidemia, hypertension, and diabetes improves medication adherence, disease control, and patients' understanding of their treatment.
Interventions
- BEHAVIORAL Telepharmacist intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,078 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02512276
The ClinicalTrials.gov registry entry for NCT02512276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,078 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telepharmacist intervention is the first listed.
NCT02512276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02512276 about?
NCT02512276 is a clinical study titled "Tele-Pharmacy Intervention to Improve Treatment Adherence". The purpose of this cluster randomized controlled trial is to evaluate whether a novel tele-pharmacist-based intervention for patients with hyperlipidemia, hypertension, and diabetes improves medication adherence, disease control, and patients' understanding of their treatment.
What is the current status of trial NCT02512276?
This trial is currently completed. It is a NA study. The enrollment target is 4,078 participants. The study started on 2015-08. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02512276?
The interventions under investigation include: Telepharmacist intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02512276?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.